Literature DB >> 7890044

Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.

I Nakamura1, N Takahashi, T Sasaki, S Tanaka, N Udagawa, H Murakami, K Kimura, Y Kabuyama, T Kurokawa, T Suda.   

Abstract

The biological role of phosphatidylinositol (PI)-3 kinase was examined in osteoclast-like multinucleated cells (OCLs) formed in co-cultures of mouse osteoblastic cells and bone marrow cells. The expression of PI-3 kinase in OCLs was confirmed by Western blot analysis. Wortmannin (WT), a specific inhibitor of PI-3 kinase, inhibited PI-3 kinase activity in OCLs both in vitro and in vivo. WT also inhibited pit-forming activity on dentine slices and disrupted a ringed structure of F-actin-containing dots (an actin ring) in OCLs in a dose-dependent manner. The inhibitory profiles of WT for pit and actin ring formation were similar to that for PI-3 kinase activity in OCLs. Electron microscopic analysis revealed that OCLs treated with WT did not form ruffled borders. Instead, numerous electron lucent vacuoles of differing sizes were found throughout the cytoplasm. These results suggest that PI-3 kinase is important in osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890044     DOI: 10.1016/0014-5793(95)00153-z

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.

Authors:  M Kobayashi; S Nagata; T Iwasaki; K Yanagihara; I Saitoh; Y Karouji; S Ihara; Y Fukui
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.

Authors:  Jing Chen-Roetling; Zhi Li; Raymond F Regan
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

4.  The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.

Authors:  Veerendra Munugalavadla; Sasidhar Vemula; Emily Catherine Sims; Subha Krishnan; Shi Chen; Jincheng Yan; Huijie Li; Paul J Niziolek; Clifford Takemoto; Alexander G Robling; Feng-Chun Yang; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

Review 5.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

6.  The Cdc42 guanine nucleotide exchange factor FGD6 coordinates cell polarity and endosomal membrane recycling in osteoclasts.

Authors:  Charlotte Steenblock; Tobias Heckel; Cornelia Czupalla; Ana Isabel Espírito Santo; Christian Niehage; Martin Sztacho; Bernard Hoflack
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

7.  c-Src control of chloride channel support for osteoclast HCl transport and bone resorption.

Authors:  John C Edwards; Christopher Cohen; Weibing Xu; Paul H Schlesinger
Journal:  J Biol Chem       Date:  2006-07-10       Impact factor: 5.157

Review 8.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

9.  Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice.

Authors:  Shoko Toyama; Naoto Tamura; Kazuhiko Haruta; Takeo Karakida; Shigeyuki Mori; Tetsuo Watanabe; Takao Yamori; Yoshinari Takasaki
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

10.  The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I.

Authors:  Makoto Kawatani; Hideo Okumura; Kaori Honda; Naoki Kanoh; Makoto Muroi; Naoshi Dohmae; Masamichi Takami; Mitsuhiro Kitagawa; Yushi Futamura; Masaya Imoto; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.